Quantcast

Latest nausea Stories

2008-12-04 07:00:00

WALTHAM, Mass., Dec. 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Eisai/Helsinn Healthcare's Aloxi's marketing message ("Better in acute, better in delayed") is rated the most influential by oncologists in the chemotherapy-induced nausea and vomiting drug market. Oncologists accurately identified Aloxi's messages with the brand, highlighting the strength of the Aloxi messaging...

2008-11-05 06:00:06

A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2008. The company also announced additional positive clinical data for its lead product, APF530, which has successfully completed a Phase 3 trial for the treatment of chemotherapy-induced nausea and vomiting (CINV). In addition, in order to better focus the company's resources on APF530 in light of current conditions in the capital markets, A.P....

2008-10-02 15:01:05

A total of 146 students at Washington's Georgetown University have been treated for a stomach illness as of Thursday, officials say. District of Columbia Health Department officials said as the number of ailing Georgetown students continues to rise, they are desperately searching for any causes of the stomach sickness, The Washington Post said. The alarming spread of the illness Wednesday prompted campus officials to shut down the university dining hall as a precaution while an...

2008-09-30 06:00:14

A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, announced today positive results from its pivotal Phase 3 study comparing the efficacy of APF530 (the Company's proprietary, sustained release formulation of granisetron) with Aloxi(R) for the prevention of chemotherapy induced nausea and vomiting (CINV). Patients in the study were classified into moderately or highly emetogenic chemotherapy levels according to the Hesketh algorithm, which assigns emetogenic levels based on...

2008-09-28 03:00:10

By Akyuz, Aygul Guvenc, Gulten; Ustunsoz, Ayfer; Kaya, Tulay Purpose: To describe the experiences of Turkish women with gynecologic cancer and their partners. Design and Methods: Qualitative research using a descriptive phenomenological approach. Setting: Gynecologic oncology outpatient clinic of the Gulhane Military Medical Academy in Ankara, Turkey. Nineteen women with gynecologic cancer aged 43-70 years and 12 partners aged 46-73 years were recruited. Data were obtained through...

2008-09-24 21:00:29

British health officials said doctors should be cautious about giving drugs to children with attention deficit hyperactivity disorder. The government said drugs such as Ritalin should only be used in severe cases and never given to children under the age of 5, The Times of London said Wednesday. The National Institute for Health and Clinical Excellence and the National Collaborating Center for Mental Health said children should first be treated with psychological therapy. The new...

2008-09-18 18:00:19

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced results of its phase 2b dose-ranging study of AMITIZA(R) (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC), conducted in Japan. The study demonstrated a statistically significant increase in mean change in spontaneous bowel movements (SBM) from baseline after one week on treatment (p less than 0.0001), the study's primary endpoint, for patients taking AMITIZA 24 micrograms twice daily versus placebo. AMITIZA...

2008-09-17 00:00:07

By The Associated Press WASHINGTON (AP) - Cancer patients will soon be able to use a medication patch to ease the debilitating nausea that often accompanies chemotherapy.The Food and Drug Administration said Monday it has approved the first anti-nausea patch for chemotherapy patients, intended to provide relief for up to five days. The patch, called Sancuso, is worn on the arm and delivers a widely used anti- nausea medicine, known as granisetron, through the skin. It is expected to be...

2008-09-16 15:00:37

DEAR DR. DONOHUE: I would like information on Meniere's disease. What caused it to happen to me? Is there a cure for it? - V.C. ANSWER: Meniere's (main-YAIRS) disease consists of a quartet of symptoms: fluctuating deafness, dizziness, tinnitus (ear noises, like ringing) and ear fullness. All of them need not be present at the same time, and they occur in episodes. The times between episodes are free of symptoms. However, with the passage of time, the symptom-free periods become shorter, and...

2008-09-16 09:00:53

ProStrakan Group has received the FDA approval for Sancuso, which is reported to be the first and only patch to provide up to five consecutive days of control of nausea and vomiting for patients receiving a moderately or highly nausea-inducing chemotherapy regimen. According to the company, Sancuso is a transdermal system, or skin patch, that delivers granisetron, its active component and an established inhibitor of nausea and vomiting, through a thin layer of adhesive that attaches the...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related